FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970781058> ?p ?o ?g. }

• W1970781058 endingPage "503" @default.
• W1970781058 startingPage "496" @default.
• W1970781058 abstract "Botulinum toxin treatment has been investigated as a minimally invasive alternative to oral medications in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (LUTS/BPH).To explore the efficacy of onabotulinumtoxinA 100 U, 200 U, and 300 U versus placebo in men with LUTS/BPH in a phase 2 dose-ranging study.A multicenter double-blind randomized, placebo-controlled 72-wk study enrolled men ≥ 50 yr of age with LUTS/BPH, International Prostate Symptom Score (IPSS) ≥ 12, total prostate volume (TPV) 30-100ml, and maximum flow rate (Q(max)) 5-15 ml/s.Single transperineal (n=63) or transrectal (n=311) administration of placebo (n=94) or onabotulinumtoxinA 100 U (n=95), 200 U (n=94), or 300 U (n=97) into the prostate transition zone.The primary efficacy end point was a change from baseline in IPSS at week 12. Secondary end points were Q(max), TPV, and transition zone volume (TZV). Analysis of covariance and the Cochran-Mantel-Haenszel method assessed the efficacy and proportion of IPSS responders. Adverse events (AEs) were assessed.Significant improvements from baseline in IPSS, Q(max), TPV, and TZV were observed for all groups, including placebo, at week 12 (p<0.001), with no significant differences between onabotulinumtoxinA and placebo. However, in an exploratory post hoc analysis, a significant reduction in IPSS versus placebo was observed with onabotulinumtoxinA 200 U in prior α-blocker users (n=180) at week 12. AEs were comparable across all groups.Reductions in LUTS/BPH symptoms were seen in all groups, including placebo, with no significant between-group differences owing to a large placebo effect from the injectable therapy. The findings from the post hoc analysis in men previously treated with α-blockers will be further explored in an appropriately designed study.http://www.Clinical Trials.gov; NCT00284518." @default.
• W1970781058 created "2016-06-24" @default.
• W1970781058 creator A5018101112 @default.
• W1970781058 creator A5035860973 @default.
• W1970781058 creator A5045014961 @default.
• W1970781058 creator A5064768277 @default.
• W1970781058 creator A5068767714 @default.
• W1970781058 creator A5069697640 @default.
• W1970781058 creator A5079097918 @default.
• W1970781058 creator A5080292758 @default.
• W1970781058 creator A5090946201 @default.
• W1970781058 date "2013-03-01" @default.
• W1970781058 modified "2023-10-18" @default.
• W1970781058 title "A Randomized Double-blind Placebo-controlled Phase 2 Dose-ranging Study of OnabotulinumtoxinA in Men with Benign Prostatic Hyperplasia" @default.
• W1970781058 cites W1969986975 @default.
• W1970781058 cites W1970782054 @default.
• W1970781058 cites W1986031402 @default.
• W1970781058 cites W1998592319 @default.
• W1970781058 cites W2002058762 @default.
• W1970781058 cites W2008454771 @default.
• W1970781058 cites W2009329619 @default.
• W1970781058 cites W2015164122 @default.
• W1970781058 cites W2020668568 @default.
• W1970781058 cites W2022332913 @default.
• W1970781058 cites W2026422425 @default.
• W1970781058 cites W2027744939 @default.
• W1970781058 cites W2036787880 @default.
• W1970781058 cites W2040027434 @default.
• W1970781058 cites W2055574600 @default.
• W1970781058 cites W2082083251 @default.
• W1970781058 cites W2086240335 @default.
• W1970781058 cites W2087378939 @default.
• W1970781058 cites W2093963005 @default.
• W1970781058 cites W2116691655 @default.
• W1970781058 cites W2121759271 @default.
• W1970781058 cites W2143903241 @default.
• W1970781058 cites W2148173212 @default.
• W1970781058 cites W2165414412 @default.
• W1970781058 cites W2318854599 @default.
• W1970781058 doi "https://doi.org/10.1016/j.eururo.2012.10.005" @default.
• W1970781058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23098762" @default.
• W1970781058 hasPublicationYear "2013" @default.
• W1970781058 type Work @default.
• W1970781058 sameAs 1970781058 @default.
• W1970781058 citedByCount "87" @default.
• W1970781058 countsByYear W19707810582012 @default.
• W1970781058 countsByYear W19707810582013 @default.
• W1970781058 countsByYear W19707810582014 @default.
• W1970781058 countsByYear W19707810582015 @default.
• W1970781058 countsByYear W19707810582016 @default.
• W1970781058 countsByYear W19707810582017 @default.
• W1970781058 countsByYear W19707810582018 @default.
• W1970781058 countsByYear W19707810582019 @default.
• W1970781058 countsByYear W19707810582020 @default.
• W1970781058 countsByYear W19707810582021 @default.
• W1970781058 countsByYear W19707810582022 @default.
• W1970781058 countsByYear W19707810582023 @default.
• W1970781058 crossrefType "journal-article" @default.
• W1970781058 hasAuthorship W1970781058A5018101112 @default.
• W1970781058 hasAuthorship W1970781058A5035860973 @default.
• W1970781058 hasAuthorship W1970781058A5045014961 @default.
• W1970781058 hasAuthorship W1970781058A5064768277 @default.
• W1970781058 hasAuthorship W1970781058A5068767714 @default.
• W1970781058 hasAuthorship W1970781058A5069697640 @default.
• W1970781058 hasAuthorship W1970781058A5079097918 @default.
• W1970781058 hasAuthorship W1970781058A5080292758 @default.
• W1970781058 hasAuthorship W1970781058A5090946201 @default.
• W1970781058 hasConcept C121608353 @default.
• W1970781058 hasConcept C126322002 @default.
• W1970781058 hasConcept C126894567 @default.
• W1970781058 hasConcept C142724271 @default.
• W1970781058 hasConcept C168563851 @default.
• W1970781058 hasConcept C197934379 @default.
• W1970781058 hasConcept C203092338 @default.
• W1970781058 hasConcept C204787440 @default.
• W1970781058 hasConcept C27081682 @default.
• W1970781058 hasConcept C2776235491 @default.
• W1970781058 hasConcept C2776312127 @default.
• W1970781058 hasConcept C2776547966 @default.
• W1970781058 hasConcept C2777562237 @default.
• W1970781058 hasConcept C2778941218 @default.
• W1970781058 hasConcept C2779478474 @default.
• W1970781058 hasConcept C2780435053 @default.
• W1970781058 hasConcept C29456083 @default.
• W1970781058 hasConcept C2991744798 @default.
• W1970781058 hasConcept C67761136 @default.
• W1970781058 hasConcept C71924100 @default.
• W1970781058 hasConceptScore W1970781058C121608353 @default.
• W1970781058 hasConceptScore W1970781058C126322002 @default.
• W1970781058 hasConceptScore W1970781058C126894567 @default.
• W1970781058 hasConceptScore W1970781058C142724271 @default.
• W1970781058 hasConceptScore W1970781058C168563851 @default.
• W1970781058 hasConceptScore W1970781058C197934379 @default.
• W1970781058 hasConceptScore W1970781058C203092338 @default.
• W1970781058 hasConceptScore W1970781058C204787440 @default.
• W1970781058 hasConceptScore W1970781058C27081682 @default.
• W1970781058 hasConceptScore W1970781058C2776235491 @default.
• W1970781058 hasConceptScore W1970781058C2776312127 @default.

• next